Atlas Trials

Safety Study of Vx006 Vaccine in Solid Tumor Patients

Clinical trial NCT02289196 · COMPLETED

Trial details

NCT number
NCT02289196
Sponsor
Vaxon Biotech
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Solid Tumor
Start date
2014-03-01
Primary completion
2014-10-01
Enrollment
23

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.